
Mechanisms of resistance to FLT3 inhibitors
Keywords: AML; Combination therapy; Multitargeted agents; NF-κB inhibition; Leukemic stem cells; PKC412; MLN518; SU-5416; SU11248; KW-2449; AC220; CEP701